Upgrade to SI Premium - Free Trial

Puma Biotech (PBYI) Tops Q2 EPS by 43c

August 8, 2019 4:12 PM
Puma Biotech (NASDAQ: PBYI) reported Q2 EPS of ($0.57), $0.43 better than the analyst estimate of ($1.00). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Management Comments

Next Articles